P90.03 A Phase 2 Trial of MRTX849 in Combination with Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
- Resource Type
- Abstract
- Source
- In
Journal of Thoracic Oncology March 2021 16(3) Supplement:S696-S696 - Subject
- Language
- ISSN
- 1556-0864